drugset / Trial / NCT03425799
Efficacy and Safety of Tranexamic Acid in Spinal Fusion Surgery
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to see if Tranexamic Acid can safely reduce bleeding in people undergoing spinal fusion surgery.
Timeline
- Start
- 2018-10-17
- Primary completion
- 2019-10-23
- Completion
- 2020-01-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tranexamic Acid | Small molecule | 3 mg/kg | Intravenous |
Indications
No indication recorded.